Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals
"Having pathologists involved in the interpretation of liquid biopsy is important, as community physicians and hospitals want to take advantage of leading-edge medical solutions by providing the best patient care in their local health system," said
"We believe that local pathologists will value
About
Forward-Looking Statements Disclaimer Statement
This news release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to be correct. Forward-looking statements are generally identifiable by the use of words like "may," "will," "should," "could," "expect," "anticipate," "estimate," "believe," "intend" or "project," or the negative of these words or other variations on these words or comparable terminology. To the extent that statements in this news release are not strictly historical, including, without limitation, statements as to our ability to identify specific
clinical conditions or improve the outcomes of cancer patients, the utility and effectiveness of our intellectual property protections, the financial impact of new contracts, and our ability to increase the number of products or services provided or the value of the Company, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our
Investor Contact: Media Contact:
LHA Investor Relations Trevelino/Keller
Jody Cain Colleen Murphy
Jcain@lhai.com cmurphy@trevelinokeller.com
310-691-7100 404-214-0722, Ext. 109
View original content with multimedia:http://www.prnewswire.com/news-releases/biocept-launches-pathology-partnership-initiative-expanding-access-of-proprietary-liquid-biopsy-testing-to-community-pathologists-and-hospitals-300538625.html
SOURCE
News Provided by Acquire Media